Skip to content

Stem cells, low intensity pulsed ultrasound or their combination for the treatment of knee osteoarthritis

Human adipose-derived Mesenchymal stem cells, low intensity pulsed ultrasound or their combination for the treatment of knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025907
Enrollment
Unknown
Registered
2019-09-14
Start date
2019-11-25
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Group 1:Intraarticular stem cells injection with shame low intensity pulsed ultrasound
Group 2:receive Intraarticular stem cells injection with low intensity pulsed ultrasound
Group 3:Normal saline with low intensity pulsed ultrasound

Sponsors

Tongji Hospital, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Males or females aged 18 Years to 70 Years old; 2. Radiological diagnosis of osteoarthritis using the American College of Rheumatology criteria; 3. Radiological grading of Grade II–III osteoarthritis (OA) of the knee as determined by a qualified radiologist using the Kellgren and Lawrence system; 4. Medial or lateral compartment OA as determined above; 5. Less than 5 degrees varus or valgus knee deformity as measured by the long mechanical axis of the knee on x-ray; 6. A minimum pain score of equal or greater than 5/10 on a visual analogue scale (VAS).

Exclusion criteria

Exclusion criteria: 1. Previous meniscectomy/significant partial meniscectomy or other knee related surgery within the last 12 months; 2. Previous intra-articular injectable therapies within the last 6 months: (1) The patients who have meniscus injury of knee joint need the surgical repair; (2) The patients who have the severe coagulation disorders, cardiopulmonary failure and so on; (3) The women who are pregnant or nursing; (4) There are electronic implants such as pacemakers in the body; (5) The patients who are infected the HIV, the virus of hepatitis or syphilis or Bleeding disorders; (6) The patients with severe cognitive impairment who cannot follow instructions to complete the treatment; (7) History of cancer; (8) Immunodeficiency patients; (9) History of systemic illness or significant organ impairment/failure (i.e., renal failure); (10) The patients who have congenital or acquired knee malformation; (11) Patients or researchers who are participating in other clinical trials believe that other reasons are not appropriate for clinical trials.

Design outcomes

Primary

MeasureTime frame
Osteoarthritis function assessment;

Secondary

MeasureTime frame
Pain assessment;Global posture analysis;Range of knee motion;cartilage thikness;

Countries

China

Contacts

Public ContactProf .Chen hong

Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

chenhong1129@hotmail.com+86 13296508243

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026